Literature DB >> 31871177

The primate model for understanding and restoring vision.

Serge Picaud1, Deniz Dalkara1, Katia Marazova1, Olivier Goureau1, Botond Roska2,3,4, José-Alain Sahel5,6,7,8.   

Abstract

Retinal degenerative diseases caused by photoreceptor cell death are major causes of irreversible vision loss. As only primates have a macula, the nonhuman primate (NHP) models have a crucial role not only in revealing biological mechanisms underlying high-acuity vision but also in the development of therapies. Successful translation of basic research findings into clinical trials and, moreover, approval of the first therapies for blinding inherited and age-related retinal dystrophies has been reported in recent years. This article explores the value of the NHP models in understanding human vision and reviews their contribution to the development of innovative therapeutic strategies to save and restore vision.

Entities:  

Keywords:  macaque; nonhuman primate; retinal diseases; vision; vision restoration

Year:  2019        PMID: 31871177      PMCID: PMC6936588          DOI: 10.1073/pnas.1902292116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  127 in total

Review 1.  Gene therapy for blindness.

Authors:  José-Alain Sahel; Botond Roska
Journal:  Annu Rev Neurosci       Date:  2013-05-31       Impact factor: 12.449

2.  The Economic Impact of Blindness in Europe.

Authors:  Usha Chakravarthy; Eliana Biundo; Rasit Omer Saka; Christina Fasser; Rupert Bourne; Julie-Anne Little
Journal:  Ophthalmic Epidemiol       Date:  2017-06-30       Impact factor: 1.648

3.  Generation of Storable Retinal Organoids and Retinal Pigmented Epithelium from Adherent Human iPS Cells in Xeno-Free and Feeder-Free Conditions.

Authors:  Sacha Reichman; Amélie Slembrouck; Giuliana Gagliardi; Antoine Chaffiol; Angélique Terray; Céline Nanteau; Anais Potey; Morgane Belle; Oriane Rabesandratana; Jens Duebel; Gael Orieux; Emeline F Nandrot; José-Alain Sahel; Olivier Goureau
Journal:  Stem Cells       Date:  2017-02-20       Impact factor: 6.277

Review 4.  Adaptive optics ophthalmoscopy: Application to age-related macular degeneration and vascular diseases.

Authors:  Michel Paques; Serge Meimon; Florence Rossant; David Rosenbaum; Sarah Mrejen; Florian Sennlaub; Kate Grieve
Journal:  Prog Retin Eye Res       Date:  2018-07-17       Impact factor: 21.198

5.  Evaluation of AAV-mediated expression of Chop2-GFP in the marmoset retina.

Authors:  Elena Ivanova; Grace-Soon Hwang; Zhuo-Hua Pan; David Troilo
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-19       Impact factor: 4.799

6.  Cone-Specific Promoters for Gene Therapy of Achromatopsia and Other Retinal Diseases.

Authors:  Guo-Jie Ye; Ewa Budzynski; Peter Sonnentag; T Michael Nork; Nader Sheibani; Zafer Gurel; Sanford L Boye; James J Peterson; Shannon E Boye; William W Hauswirth; Jeffrey D Chulay
Journal:  Hum Gene Ther       Date:  2016-01       Impact factor: 5.695

7.  Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10.

Authors:  Morgan L Maeder; Michael Stefanidakis; Christopher J Wilson; Reshica Baral; Luis Alberto Barrera; George S Bounoutas; David Bumcrot; Hoson Chao; Dawn M Ciulla; Jennifer A DaSilva; Abhishek Dass; Vidya Dhanapal; Tim J Fennell; Ari E Friedland; Georgia Giannoukos; Sebastian W Gloskowski; Alexandra Glucksmann; Gregory M Gotta; Hariharan Jayaram; Scott J Haskett; Bei Hopkins; Joy E Horng; Shivangi Joshi; Eugenio Marco; Rina Mepani; Deepak Reyon; Terence Ta; Diana G Tabbaa; Steven J Samuelsson; Shen Shen; Maxwell N Skor; Pam Stetkiewicz; Tongyao Wang; Clifford Yudkoff; Vic E Myer; Charles F Albright; Haiyan Jiang
Journal:  Nat Med       Date:  2019-01-21       Impact factor: 53.440

8.  ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation.

Authors:  John Y Lin; Per Magne Knutsen; Arnaud Muller; David Kleinfeld; Roger Y Tsien
Journal:  Nat Neurosci       Date:  2013-09-01       Impact factor: 24.884

9.  Taurine provides neuroprotection against retinal ganglion cell degeneration.

Authors:  Nicolas Froger; Lucia Cadetti; Henri Lorach; Joao Martins; Alexis-Pierre Bemelmans; Elisabeth Dubus; Julie Degardin; Dorothée Pain; Valérie Forster; Laurent Chicaud; Ivana Ivkovic; Manuel Simonutti; Stéphane Fouquet; Firas Jammoul; Thierry Léveillard; Ryad Benosman; José-Alain Sahel; Serge Picaud
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

10.  Multiple ophthalmic abnormalities in an infant rhesus macaque (Macaca mulatta).

Authors:  Erin P Ribka; Richard R Dubielzig
Journal:  J Med Primatol       Date:  2008-02       Impact factor: 0.667

View more
  20 in total

1.  Cell atlas of aqueous humor outflow pathways in eyes of humans and four model species provides insight into glaucoma pathogenesis.

Authors:  Tavé van Zyl; Wenjun Yan; Alexi McAdams; Yi-Rong Peng; Karthik Shekhar; Aviv Regev; Dejan Juric; Joshua R Sanes
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-27       Impact factor: 11.205

2.  From basic brain research to treating human brain disorders.

Authors:  Elizabeth A Buffalo; J Anthony Movshon; Robert H Wurtz
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

Review 3.  Modeling genetic diseases in nonhuman primates through embryonic and germline modification: Considerations and challenges.

Authors:  Jenna K Schmidt; Kathryn M Jones; Trevor Van Vleck; Marina E Emborg
Journal:  Sci Transl Med       Date:  2022-03-02       Impact factor: 19.319

Review 4.  3D engineering for optic neuropathy treatment.

Authors:  Wenjing Xuan; Aji Alex Moothedathu; Tuo Meng; David C Gibson; Jinhua Zheng; Qingguo Xu
Journal:  Drug Discov Today       Date:  2020-10-07       Impact factor: 7.851

5.  Targeting of miR-33 ameliorates phenotypes linked to age-related macular degeneration.

Authors:  Gopalan Gnanaguru; Alexandre Wagschal; Justin Oh; Kahira L Saez-Torres; Tong Li; Ryan E Temel; Mark E Kleinman; Anders M Näär; Patricia A D'Amore
Journal:  Mol Ther       Date:  2021-03-17       Impact factor: 12.910

Review 6.  Optogenetic Gene Therapy for the Degenerate Retina: Recent Advances.

Authors:  Michelle E McClements; Federica Staurenghi; Robert E MacLaren; Jasmina Cehajic-Kapetanovic
Journal:  Front Neurosci       Date:  2020-11-11       Impact factor: 4.677

7.  Comprehensive Preclinical Assessment of ADVM-022, an Intravitreal Anti-VEGF Gene Therapy for the Treatment of Neovascular AMD and Diabetic Macular Edema.

Authors:  Claire M Gelfman; Ruslan Grishanin; Kristina Oresic Bender; Aivan Nguyen; Judith Greengard; Pallavi Sharma; Julio Nieves; Szilárd Kiss; Mehdi Gasmi
Journal:  J Ocul Pharmacol Ther       Date:  2021-04       Impact factor: 2.671

Review 8.  Gene Therapy to the Retina and the Cochlea.

Authors:  Ryan Crane; Shannon M Conley; Muayyad R Al-Ubaidi; Muna I Naash
Journal:  Front Neurosci       Date:  2021-03-17       Impact factor: 4.677

Review 9.  Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss.

Authors:  Gayle B Collin; Navdeep Gogna; Bo Chang; Nattaya Damkham; Jai Pinkney; Lillian F Hyde; Lisa Stone; Jürgen K Naggert; Patsy M Nishina; Mark P Krebs
Journal:  Cells       Date:  2020-04-10       Impact factor: 7.666

Review 10.  Opportunities and limitations of genetically modified nonhuman primate models for neuroscience research.

Authors:  Guoping Feng; Frances E Jensen; Henry T Greely; Hideyuki Okano; Stefan Treue; Angela C Roberts; James G Fox; Sarah Caddick; Mu-Ming Poo; William T Newsome; John H Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.